Delayed hematological recovery following autologous transplantation utilizing peripheral blood stem cells harvested after treatment with arsenic trioxide

Pathology and Oncology Research

Volumn 14, Issue 4, 2008, Pages 387-390

  Ueki, Toshimitsu ^a   Ohashi, Kazuteru ^a   Jinta, Minako ^a   Okuyama, Yoshiki ^a   Hiruma, Kiyoshi ^a   Akiyama, Hideki ^a   Sakamaki, Hisashi ^a  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Acute promyelocytic leukemia; Arsenic trioxide; Autologous PBSCT; Delayed hematological recovery

Indexed keywords

ARSENIC TRIOXIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; MELPHALAN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID;

ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; CANCER RADIOTHERAPY; CASE REPORT; CONVALESCENCE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; MALE; PANCYTOPENIA; PROMYELOCYTIC LEUKEMIA; REMISSION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; ARSENICALS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OXIDES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 60049099401     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9049-5     Document Type: Article

References (10)

1. Soignet SL, Maslak P, Wang Z-G, et al (1998) Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341-1348
2. Niu C, Yan H, Sun HP, et al (1999) Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: remission induction, follow-up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients. Blood 94:3315-3324
3. Douer D, Hu W, Giralt S, et al (2003) Arsenic trioxide (trisenox) therapy for acute promyelocytic leukemia in the setting of hematopoietic stem cell transplantation. Oncologist 8:132-140
4. de Botton S, Fawaz A, Chevret S, et al (2005) Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European Acute Promyelocytic Leukemia Group. J Clin Oncol 23:120-126
5. Ohno R, Asou N, Japan Adult Leukemia Study Group (2004) The recent JALSG study for newly diagnosed patients with acute promyelocytic leukemia (APL). Ann Hematol 83 Suppl 1:77-78
6. Mehta J, Powles R, Singhal S, et al (1996) Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission. Bone Marrow Transplant 18:119-123
7. Mikoshiba M, Ohashi K, Takei N, et al (2002) Successful unrelated bone marrow transplantation after arsenic trioxide treatment in a patient with relapsed acute promyelocytic leukemia. Int J Hematol 75:104-106
8. Beguin Y, Baudoux E, Sautois B, et al (1998) Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion 38:199-208
9. Lanza F, Campioni D, Moretti S, et al (2001) CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long- term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation. Exp Hematol 29:1484- 1493
10. Douer D, Tallman MS (2005) Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. J Clin Oncol 23:2396-2410